Natixis Advisors, L.P. Embecta Corp. Transaction History
Natixis Advisors, L.P.
- $51.3 Billion
- Q3 2024
A detailed history of Natixis Advisors, L.P. transactions in Embecta Corp. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 30,735 shares of EMBC stock, worth $597,795. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,735
Previous 29,087
5.67%
Holding current value
$597,795
Previous $364,000
18.96%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EMBC
# of Institutions
405Shares Held
51.1MCall Options Held
162KPut Options Held
61K-
Black Rock Inc. New York, NY9.19MShares$179 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$136 Million0.0% of portfolio
-
River Road Asset Management, LLC3.48MShares$67.6 Million0.69% of portfolio
-
American Century Companies Inc Kansas City, MO3.02MShares$58.7 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.73MShares$53.1 Million0.72% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $1.12B
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...